Success Story: NIW Greenlight for Colombian Researcher – Approved Swiftly with Our Expert Help

Client’s Testimonial:

“Thank you so much for the service. I’m very satisfied with the process and the results.”

On March 24^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Assistant in the Field of Economics (Approval Notice).

General Field: Economics

Position at the Time of Case Filing: Research Assistant

Country of Origin: Colombia

State of Residence at the Time of Filing: District of Columbia

Approval Notice Date: March 24^th, 2025

Processing Time: 1 month, 20 days (Premium Processing Requested)

Case Summary:

We are pleased to share the success story of an economist whose I-140 NIW (National Interest Waiver) petition was approved in just 1 month and 20 days under premium processing. This swift approval highlights the growing recognition of research at the intersection of artificial intelligence and health economics, and its significance in addressing critical issues such as healthcare affordability and equitable drug access.

The client holds a Master of Public Administration (M.P.A.) and is currently employed in the research sector, with plans to take on a consulting role in global development. His proposed endeavor focuses on designing advanced AI frameworks and data-driven policy models that guide the ethical implementation of AI-powered market intelligence in the healthcare and pharmaceutical sectors. By optimizing drug pricing mechanisms and improving healthcare accessibility, his work contributes directly to improving patient outcomes and reducing healthcare disparities.

Filed under the EB-2 NIW category, the petition featured:

● 4 peer-reviewed journal articles,

● 2 preprints, and

● 1 book publication,

● With a total of 84 citations according to Google Scholar.

To demonstrate the impact of his work, the petition highlighted the client’s widely cited research on pharmaceutical policy reforms and contraceptive access. His findings have not only informed academic discussions but have also been incorporated into health policy strategies by governmental bodies and international organizations.

In addition, the client’s work has influenced regulatory practices in countries aiming to improve access to essential medications. His models have guided policies that balance drug pricing with accessibility and have been used to strengthen monitoring systems designed to prevent unintended effects of price control mechanisms. His expertise in deploying AI tools for health market analysis positions him as a leader in shaping future frameworks for healthcare equity and affordability.

To further support the petition, two letters of recommendation were provided by leading experts in the fields of public health and economic development. These letters confirmed the national relevance and exceptional quality of the client’s research.

“[Client’s] results indicated that strong market monitoring and price interventions must be implemented in the Colombian pharmaceutical industry, which highlights how his research contributes to more efficient policies to reduce costs and maintain access to essential medications within the United States.”

With a carefully constructed petition that demonstrated the merit, national importance, and feasibility of the proposed endeavor, NAILG successfully secured this favorable result. We are proud to have supported this client and look forward to his continued contributions to economic innovation, digital policy, and AI-driven healthcare reform in the United States.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.